ArticleJournal of extracellular vesicles2022

A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.

Linglei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.